These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

301 related items for PubMed ID: 31190791

  • 1. Long-term use of inhaled glucocorticoids in patients with stable chronic obstructive pulmonary disease and risk of bone fractures: a narrative review of the literature.
    Caramori G, Ruggeri P, Arpinelli F, Salvi L, Girbino G.
    Int J Chron Obstruct Pulmon Dis; 2019; 14():1085-1097. PubMed ID: 31190791
    [Abstract] [Full Text] [Related]

  • 2. Inhaled corticosteroids effects on bone in asthmatic and COPD patients: a quantitative systematic review.
    Richy F, Bousquet J, Ehrlich GE, Meunier PJ, Israel E, Morii H, Devogelaer JP, Peel N, Haim M, Bruyere O, Reginster JY.
    Osteoporos Int; 2003 May; 14(3):179-90. PubMed ID: 12730758
    [Abstract] [Full Text] [Related]

  • 3. Bone mineral density and fractures in older men with chronic obstructive pulmonary disease or asthma.
    Dam TT, Harrison S, Fink HA, Ramsdell J, Barrett-Connor E, Osteoporotic Fractures in Men (MrOS) Research Group.
    Osteoporos Int; 2010 Aug; 21(8):1341-9. PubMed ID: 19816753
    [Abstract] [Full Text] [Related]

  • 4. Prevalence and progression of osteoporosis in patients with COPD: results from the TOwards a Revolution in COPD Health study.
    Ferguson GT, Calverley PMA, Anderson JA, Jenkins CR, Jones PW, Willits LR, Yates JC, Vestbo J, Celli B.
    Chest; 2009 Dec; 136(6):1456-1465. PubMed ID: 19581353
    [Abstract] [Full Text] [Related]

  • 5. Long-term effects of inhaled corticosteroids on bone mineral density in older women with asthma or COPD: a registry-based cohort study.
    Chen W, Johnson KM, FitzGerald JM, Sadatsafavi M, Leslie WD.
    Arch Osteoporos; 2018 Oct 29; 13(1):116. PubMed ID: 30374631
    [Abstract] [Full Text] [Related]

  • 6. Risk of fractures with inhaled corticosteroids in COPD: systematic review and meta-analysis of randomised controlled trials and observational studies.
    Loke YK, Cavallazzi R, Singh S.
    Thorax; 2011 Aug 29; 66(8):699-708. PubMed ID: 21602540
    [Abstract] [Full Text] [Related]

  • 7. Impact of long-term inhaled corticosteroid therapy on bone mineral density: results of a meta-analysis.
    Halpern MT, Schmier JK, Van Kerkhove MD, Watkins M, Kalberg CJ.
    Ann Allergy Asthma Immunol; 2004 Feb 29; 92(2):201-7; quiz 207-8, 267. PubMed ID: 14989387
    [Abstract] [Full Text] [Related]

  • 8. Effects of long-term inhaled corticosteroid treatment on fragility fractures in older women: the Manitoba BMD registry study.
    Ng BC, Leslie WD, Johnson KM, FitzGerald JM, Sadatsafavi M, Chen W.
    Osteoporos Int; 2020 Jun 29; 31(6):1155-1162. PubMed ID: 32123939
    [Abstract] [Full Text] [Related]

  • 9. Association between inhaled corticosteroids and upper respiratory tract infection in patients with chronic obstructive pulmonary disease: a meta-analysis of randomized controlled trials.
    Chen H, Feng Y, Wang K, Yang J, Du Y.
    BMC Pulm Med; 2020 Oct 28; 20(1):282. PubMed ID: 33115481
    [Abstract] [Full Text] [Related]

  • 10. Impact of long-term treatment with low-dose inhaled corticosteroids on the bone mineral density of chronic obstructive pulmonary disease patients: aggravating or beneficial?
    Mathioudakis AG, Amanetopoulou SG, Gialmanidis IP, Chatzimavridou-Grigoriadou V, Siasos G, Evangelopoulou E, Mathioudakis GA.
    Respirology; 2013 Jan 28; 18(1):147-53. PubMed ID: 22985270
    [Abstract] [Full Text] [Related]

  • 11. Inhaled corticosteroids for stable chronic obstructive pulmonary disease.
    Yang IA, Fong KM, Sim EH, Black PN, Lasserson TJ.
    Cochrane Database Syst Rev; 2007 Apr 18; (2):CD002991. PubMed ID: 17443520
    [Abstract] [Full Text] [Related]

  • 12. Inhaled corticosteroids and fractures in chronic obstructive pulmonary disease: current understanding and recommendations.
    Moon JY, Sin DD.
    Curr Opin Pulm Med; 2019 Mar 18; 25(2):165-172. PubMed ID: 30507646
    [Abstract] [Full Text] [Related]

  • 13. Inhaled corticosteroids versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease.
    Spencer S, Evans DJ, Karner C, Cates CJ.
    Cochrane Database Syst Rev; 2011 Oct 05; (10):CD007033. PubMed ID: 21975759
    [Abstract] [Full Text] [Related]

  • 14. Effects of inhaled corticosteroids /long-acting agonists in a single inhaler versus inhaled corticosteroids alone on all-cause mortality, pneumonia, and fracture in chronic obstructive pulmonary disease: A nationwide cohort study 2002-2013.
    Cho KH, Kim YS, Linton JA, Nam CM, Choi Y, Park EC.
    Respir Med; 2017 Sep 05; 130():75-84. PubMed ID: 29206637
    [Abstract] [Full Text] [Related]

  • 15. Inhaled glucocorticoids are associated with vertebral fractures in COPD patients.
    Gonçalves PA, Dos Santos Neves R, Neto LV, Madeira M, Guimarães FS, Mendonça LMC, Lopes AJ, Farias MLF.
    J Bone Miner Metab; 2018 Jul 05; 36(4):454-461. PubMed ID: 28766137
    [Abstract] [Full Text] [Related]

  • 16. [Risk of pneumonia during long term regular treatment of stable COPD with inhaled glucocorticoids: a systematic review.].
    Arpinelli F, Caramori G, Magnoni MS.
    Recenti Prog Med; 2017 Apr 05; 108(4):175-182. PubMed ID: 28492586
    [Abstract] [Full Text] [Related]

  • 17. Comparing the effectiveness of small-particle versus large-particle inhaled corticosteroid in COPD.
    Postma DS, Roche N, Colice G, Israel E, Martin RJ, van Aalderen WM, Grigg J, Burden A, Hillyer EV, von Ziegenweidt J, Gopalan G, Price D.
    Int J Chron Obstruct Pulmon Dis; 2014 Apr 05; 9():1163-86. PubMed ID: 25378918
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.